beta-D-GlcpNAc-(1->6)-alpha-D-GalpNAc

Term ID

CHEBI:71411

Synonyms

2-(acetylamino)-6-O-[2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl]-2-deoxy-alpha-D-galactopyranose
2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->6)-2-acetamido-2-deoxy-alpha-D-galactopyranose
2-acetamido-6-O-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-2-deoxy-alpha-D-galactopyranose
beta-D-GlcNAc-(1->6)-alpha-D-GalNAc
GlcNAcb1-6GalNAca
GlcNAcbeta1-6GalNAcalpha
N-acetyl-beta-D-glucosaminyl-(1->6)-N-acetyl-alpha-D-galactosamine
WURCS=2.0/2,2,1/[a2112h-1a_1-5_2*NCC/3=O][a2122h-1b_1-5_2*NCC/3=O]/1-2/a6-b1

Definition

beta-D-GlcpNAc-(1->6)-D-GalpNAc in which the anomeric configuration of the reducing-end GalNAc residue is alpha.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: beta-D-GlcpNAc-(1->6)-D-GalpNAc

beta-D-GlcpNAc-(1->6)-D-GalpNAc Show first 5 Terms
has_role: epitope

epitope Show first 5 Terms
inverse has_functional_parent: beta-D-GlcpNAc-(1->6)-alpha-D-GalpNAc3S

beta-D-GlcpNAc-(1->6)-alpha-D-GalpNAc3S Show first 5 Terms

Phenotype

Phenotype resulting from beta-D-GlcpNAc-(1->6)-alpha-D-GalpNAc

Phenotype where environments contain beta-D-GlcpNAc-(1->6)-alpha-D-GalpNAc

Phenotype modified by environments containing beta-D-GlcpNAc-(1->6)-alpha-D-GalpNAc

Human Disease Model